Coverage
-
January 27, 2015
Boehringer Ingelheim Pharmaceuticals Inc. on Monday agreed to dismiss its New Jersey federal suit accusing Amneal Pharmaceuticals LLC of patent infringement over its generic version of stroke-prevention drug Aggrenox, saying they have reached a licensing deal.
1 other articles on this case.
View all »